Patent Assignment
Reel/Frame 058542/0479
Assignment of Assignor's Interest
Recorded: 2022-01-04
Pages: 3
Assignee
TRELLIS BIOSCIENCE, INC.
702 MARSHALL ST., SUITE 614, REDWOOD CITY, CALIFORNIA, 94063
Covered Property
(1)
Therapeutic Protein Formulations Comprising Anti-Dnabii Antibodies and Uses Thereof
Application:
17/565,134 →
Publication:
US 2022/0204600